Activating Collaborative CIS Support Via Targeted Provider Mailing
NCT ID: NCT00873288
Last Updated: 2023-03-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
254 participants
INTERVENTIONAL
2006-10-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Decision Aids About Early Stage Prostate Cancer
NCT02053389
Shared Decision Making: Prostate Cancer Screening
NCT00207649
Educational Interventions for Patients With DCIS
NCT00148655
Email-based Reminders Promoting Recommended Pediatric Preventative Visits
NCT05317884
Intervention to Educate and Improve Underrepresented Populations' Participation in Clinical Trials
NCT04863092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Compare the effect of a usual care mailing intervention vs a Cancer Information Service (CIS) support mailing intervention on the likelihood that women with an abnormal Pap test will keep their medical follow-up appointments and be satisfied with how they talk to their provider.
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 intervention arms.
* Arm I (Usual-care mailing intervention): Patients receive a generic letter reminding them of their follow-up colposcopy appointment.
* Arm II (Cancer Information Service \[CIS\] support mailing intervention): Patients receive a targeted letter reminding them of their follow-up colposcopy appointment, asking them or someone they designate to call the CIS, and suggesting some questions to ask the CIS about colposcopies and Pap tests.
At their follow-up appointments, all patients undergo an exit interview to compare patient satisfaction between the 2 interventions. Patients in arm II also answer questions about their CIS experience, and if the intervention made their follow-up visit less difficult.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual Care mailing intervention
routine colposcopy reminder letter mailed
Usual care mailing intervention
routine colposcopy reminder letter
CIS support mailing intervention
Mailed reminder plus provider recommendation to call CIS and sample questions to ask
CIS support mailing intervention
Mailed reminder plus provider recommendation to call CIS and sample questions to ask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Usual care mailing intervention
routine colposcopy reminder letter
CIS support mailing intervention
Mailed reminder plus provider recommendation to call CIS and sample questions to ask
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received an abnormal Pap test result
* Scheduled for a colposcopy within 6 months of their Pap test at either the Erie Family Health Center or the Prentice Ambulatory Clinic
PATIENT CHARACTERISTICS:
* Female
* Able to communicate in either English or Spanish
* Clinic staff will review patient charts to determine eligibility
PRIOR CONCURRENT THERAPY:
* Not specified
Exclusion Criteria
* unable to communicate in English or Spanish
* no address to which a letter can be mailed
18 Years
100 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bonnie Spring
Director, Center for Behavior and Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bonnie Spring, PhD
Role: PRINCIPAL_INVESTIGATOR
Robert H. Lurie Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
Erie Family Health Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cofta-Woerpel L, Randhawa V, McFadden HG, Fought A, Bullard E, Spring B. ACCISS study rationale and design: activating collaborative cancer information service support for cervical cancer screening. BMC Public Health. 2009 Dec 2;9:444. doi: 10.1186/1471-2458-9-444.
Simon MA, Cofta-Woerpel L, Randhawa V, John P, Makoul G, Spring B. Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication. Patient Educ Couns. 2010 Oct;81(1):106-12. doi: 10.1016/j.pec.2009.11.022. Epub 2010 Jan 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.